Goolgle Scholar : https://scholar.google.com/citations?hl=ko&user=BM5CXRMAAAAJ&view_op=list_works&sortby=pubdate
Main Author>
2025]
Anthropometrics, cancer risks, and survival outcomes in adult patients with glioma - a systematic review and meta-analysis. Ahn J, Kim J, Shin C, Ahn S. Acta Neurochir (Wien). 2025;167(1):188. Published 2025 Jul 10.
https://doi:10.1007/s00701-025-06579-4
2024]
Impact of anesthesia type on surgical outcomes and medical complications in chronic subdural hematoma surgery. Ahn S, Park JS, Cho CB, Yang SH, Kim YI. J Clin Neurosci. 2024 Oct 19;129:110876. doi: 10.1016/j.jocn.2024.110876. Epub ahead of print. PMID: 39427458.
https://doi.org/10.1016/j.jocn.2024.110876
Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model. Park J, Park SA, Kim YS, Kim D, Shin S, Lee SH, Jeun SS, Chung YJ, Ahn S. Biomed Pharmacother. 2024 Apr;173:115790. doi: 10.1016/j.biopha.2023.115790. Epub 2024 Mar 1. PMID: 38431436.
https://doi.org/10.1016/j.biopha.2023.115790
From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma. Kim J, Choi H, Jeun SS, Ahn S. Cancer Lett. 2024 Apr 28;588:216714. doi: 10.1016/j.canlet.2024.216714. Epub 2024 Feb 17. PMID: 38369003.
https://doi.org/10.1016/j.canlet.2024.216714
Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma. Kim D, Park J, Park HC, Zhang S, Park M, Park SA, Lee SH, Lee YS, Park JS, Jeun SS, Chung YJ, Ahn S. Cancer Cell Int. 2024 Jan 18;24(1):36. doi: 10.1186/s12935-024-03225-4. PMID: 38238738; PMCID: PMC10795458.
https://doi.org/10.1186/s12935-024-03225-4
2023]
Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy. Choi H, Kim TG, Jeun SS, Ahn S. Cancer Lett. 2023 Sep 1;571:216335. doi: 10.1016/j.canlet.2023.216335. Epub 2023 Aug 5. PMID: 37544475.
https://doi.org/10.1016/j.canlet.2023.216335
Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma. Choi H, Baek IC, Park SA, Park JS, Jeun SS, Kim TG, Ahn S. J Clin Med. 2023 Jul 19;12(14):4780. doi: 10.3390/jcm12144780. PMID: 37510895; PMCID: PMC10380963.
https://doi.org/10.3390/jcm12144780
A clinical evaluation of cystic features in patients with newly diagnosed glioblastoma with IDH-wildtype. Kim MJ, Park JS, Jeun SS, Ahn S. Clin Neurol Neurosurg. 2023 May;228:107708. doi: 10.1016/j.clineuro.2023.107708. Epub 2023 Apr 4. PMID: 37043844.
https://doi.org/10.1016/j.clineuro.2023.107708
2022]
Compassionate use of recombinant human IL-7-hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma. Ahn S, Park JS, Kim H, Heo M, Sung YC, Jeun SS. Cancer Med. 2022;10.1002/cam4.5467.
https://doi:10.1002/cam4.5467 (IF=4.771)
Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands. Choi H, Lee Y, Park SA, Lee JH, Park J, Park JH, Lee HK, Kim TG, Jeun SS, Ahn S. Oncoimmunology. 2022 Oct 30;11(1):2138152.
https://doi.org/10.1080/2162402X.2022.2138152 (IF = 7.723)
Association between Temporal Muscle Thickness and Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis. Kim YI, Shin JY, Yang SH, Kim HH, Shim BY, Ahn S. Current Oncology. 2022 Sep;29(9):6463-71.
https://doi.org/10.3390/curroncol29090508 (IF=3.109)
Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments. Ahn J, Shin C, Kim YS, Park JS, Jeun SS, Ahn S. Brain Tumor Res Treat. 2022 Jul;10(3):135-143.
https://doi.org/10.14791/btrt.2022.0010
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma. Ahn S, Kim YI, Shin JY, Park JS, Yoo C, Lee YS, Hong YK, Jeun SS, Yang SH. Oncology Letters. 2022 Apr;23(4):114.
https://doi.org/10.3892/ol.2022.13234 (IF=3.111)
Comparative analysis of safety and efficacy in subperiosteal versus subdural drainage after burr-hole trephination for chronic subdural hematoma. Hwang Y, Choi S, Kim YS, Park JS, Choi JH, Jeun SS, Ahn S. Clin Neurol Neurosurg. 2022 Jan;212:107068.. (IF = 1.885) (Cited by 2)
https://doi.org/10.1016/j.clineuro.2021.107068
2021]
HLA polymorphisms and risk of glioblastoma in Koreans. Choi SS, Choi H, Baek IC, Park SA, Park JS, Kim TG, Jeun SS, Ahn S. PLoS One. 2021 Dec 9;16(12):e0260618.
https://doi.org/10.1371/journal.pone.0260618 (IF = 3.752)
Association between height and the risk of primary brain malignancy in adults: a nationwide population-based cohort study. Ahn S, Han K, Lee JE, Jeun SS, Park YM, Joo W, Yang SH. Neurooncol Adv. 2021 Jul 8;3(1):vdab098.
https://doi.org/10.1093/noajnl/vdab098 (Cited by 1)
Associations of General and Abdominal Obesity with the Risk of Glioma Development. Cancers (Basel). Ahn S, Han K, Lee JE, Jeun SS, Park YM, Yang SH. 2021;13(12):2859. Published 2021 Jun 8.
https://doi.org/10.3390/cancers13122859 (IF = 6.575) (Cited by 2)
Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma. An G, Ahn S, Park JS, Jeun SS, Hong YK. J Cancer Res Clin Oncol. 2021;147(3):901-909.
https://doi.org/10.1007/s00432-020-03386-5 (IF = 4.322) (Cited by 21)
Impact of Body Mass Index on Survival Outcome in Patients with Newly Diagnosed Glioblastoma: A Retrospective Single-Center Study. Cha JY, Park JS, Hong YK, Jeun SS, Ahn S. Integr Cancer Ther. 2021;20:1534735421991233.
https://doi:10.1177/1534735421991233 (IF = 3.077) (Cited by 4)
2020]
Stereotactic radiosurgery as a primary treatment modality for pineal parenchymal tumors. Ahn S, Park JS, Song JH, Hong YK, Jeun SS. International Journal of Radiation Research. 2020 Oct 1;18(4):785-90.
http://dx.doi.org/10.52547/ijrr.18.4.785 (IF = 0.724)
Surgical Experience in Prevention of Postoperative CSF Leaks Using Abdominal Fat Grafts in Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas. Ahn S, Park JS, Kim DH, Kim SW, Jeun SS. J Neurol Surg B Skull Base. 2021;82(5):522-527.
https://doi.org/10.1055/s-0040-1712179 (IF = 1.407) (Cited by 2)
Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma. Lee C, Ahn S, Park JS, Song JH, Hong YK, Jeun SS. Brain Tumor Res Treat. 2020;8(2):71-76.
https://doi.org/10.14791/btrt.2020.8.e12 (Cited by 8)
Cigarette Smoking Is Associated with Increased Risk of Malignant Gliomas: A Nationwide Population-Based Cohort Study. Ahn S, Han KD, Park YM, et al. Cancers (Basel). 2020;12(5):1343. Published 2020 May 25.
https://doi.org/10.3390/cancers12051343 (IF = 6.575) (Cited by 10)
The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma. Ahn S, Park JS, Jang J, et al. J Clin Neurosci. 2020;71:21-25.
https://doi.org/10.1016/j.jocn.2019.11.017 (IF = 2.116) (Cited by 7)
~2019]
Effect of a Time Delay for Concomitant Chemoradiation After Surgery for Newly Diagnosed Glioblastoma: A Single-Institution Study with Subgroup Analysis According to the Extent of Tumor Resection. Ahn S, Park JS, Song JH, Jeun SS, Hong YK. World Neurosurg. 2020;133:e640-e645.
https://doi.org/10.1016/j.wneu.2019.09.122 (IF = 2.210) (Cited by 10)
Extra-Axial and Clear Cell Type Ependymoma, Mimicking a Convexity Meningioma. Ahn S, Kim YJ, Lee YS, Jeun SS. Brain Tumor Res Treat. 2017;5(2):127-130.
https://doi:10.14791/btrt.2017.5.2.127 (Cited by 1)
Surgical experiences of anterior petrosal approach for skull base tumor resection in a single institution. S Ahn, SH Yang, JH Sung, SW Lee. J Korean Skull Base Soc
2016;11(2):48-52.
HLA and Disease Associations in Koreans. Ahn S, Choi HB, Kim TG. Immune Netw. 2011;11(6):324-335.
https://doi:10.4110/in.2011.11.6.324 (IF = 5.851) (Cited by 19)